Skip to main content

Name
Caitlyn Vlasschaert

Wed, 09/23/2020 - 11:48

What an excellent talk by Dr. Lee! Thank you, Michaela, for your expert moderation of the ensuing discussion with the TMED class.

Following our chat, I turned to Twitter to read more about how life-changing imatinib has been for patients. I landed on the page of the "longest surviving Gleevec patient", one of the first patients enrolled in its Phase 1 trials, Mel Mann (https://twitter.com/MelDMann). He has catalogued the events of his life since learning he had CML in the mid-'90s. He has shared newspaper clippings of articles asking the public to help him find a bone marrow donor in 1995 (https://twitter.com/MelDMann/status/942954135376334848) followed a video describing his miraculous convalescence from 1998 onward (https://twitter.com/MelDMann/status/942954135376334848). An inspirational story for all of us working in translational medicine.

Name
Caitlyn Vlasschaert

Plain text

  • No HTML tags allowed.
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.